Your support of Dr. Figlin’s work highlights the combination that makes City of Hope unique
 Robert Figlin, M.D., a nationally-recognized leader in genitourinary and thoracic oncology, wanted to be part of "an institution committed to patient care." |
Members of the City of Hope family wake up in the morning and go to sleep at night thinking about how to keep patient care at the center of cancer research," Dr. Robert Figlin says.
That's why, in September 2006, Dr. Figlin joined the City of Hope team. Today he is associate director of clinical research, chair of the division of medical oncology and therapeutics research, and Arthur and Rosalie Kaplan Professor of Medical Oncology.
His titles are a mouthful, but Dr. Figlin's vision is straightforward: "As an institution committed to the patient, we do our work to benefit the individual and the family dealing with cancer. Even though we are researching a condition that affects many people, we never lose sight of the individual person."
Bringing a nationally recognized expert such as Dr. Figlin to our labs is a coup for City of Hope, but it's men, women and children with cancer who will really benefit.
The importance of his research has already been recognized by the Phase One Foundation, which awarded City of Hope and Dr. Figlin a $500,000 grant to identify and develop new, targeted anti-cancer therapies.
"City of Hope is uniquely positioned to translate clinical research to patients in a rapid, safe and effective way. This allows me to do kidney research in an environment that champions both research and clinical care."
Your support of City of Hope makes possible the special blend of patient care and visionary science that attracts the world's leading cancer researchers like Dr. Robert Figlin. Your gift is an investment in the future of patient care ... and in the lives of people fighting cancer today.
